Brand India Pharma at CPhI Worldwide, Frankfurt, Germany, 2017

Brand India Pharma at CPhI Worldwide, October 24-26, 2017 Frankfurt, Germany
CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 42,000 visiting pharma professionals over three days. 2,500+ exhibitors from 153 countries gather at the event to network and take advantage of more than 150 free industry seminars. Every sector of the pharmaceutical market is represented under one roof, this year in Frankfurt. Attending CPhI Worldwide is the most cost effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends. The exhibition showcases cover the whole spectrum of pharmaceutical manufacturing and ingredients sourcing, offering products and services that cover the entire supply chain.
Brand India Pharma Campaign at CPhI Worldwide
Brand India Pharma Campaign is an ongoing exercise being carried out by Pharmexcil in association with IBEF and Ministry of Commerce, Govt. of India. As a result of sustained effort in this regard, Indian pharma's presence in CPhI Worldwide has been very well noticed/ appreciated by all stakeholders. Govt. of India is making a conscious effort to scale up the look and feel of India Pavilion and branding of Indian Pharma at different strategic locations at the venue. Following value additions have been the Hallmark of India's participation in CPhI World Wide since last five years:
- Well-designed India Pavilion and specially designed Common are with complete Branding images giving it a unique identity.
- Buyer Seller meets in India Pavilion with the visiting/ invited buyers.
- Increased Digital / Show daily coverage with more coverage on exhibitors in India pavilion during the event
In fact through these activities we have been able to make mark of India's presence in CPhI World Wide and now buyers from all across the globe are looking forward for planned/ special visits to Indian exporters in India pavilion. All the above activities would continue this year also.
Media Interactions

October 25, 10:30 am: Interview with Generics Bulletin (Aidan Fry)
October 25, 11:30 am: Interview with C&EN (Rick Mullin)
October 25, 02:00 pm: Flora Southey (in-PharmaTechnologist
October 26, 10:30 am: Interview with The Medicine Maker (Stephanie Sutton)
Seminar on Indian Pharma
- India’s Contribution to Global Healthcare: A perspective on Affordability, Accessibility and Efficacy
24th October 2017 - Venue:
Esprit, Hall 9 level 1, Messe Frankfurt, Frankfurt, Germany - Registration
11.00 AM - 11.30 AM - Welcome Address
H.E Mrs. Pratibha Parkar Consul General, Consulate General of India, Frankfurt, Germany
11.30 AM - 11.40 AM - Role of Indian Pharma: A Global Perspective
Mr Madan Mohan Reddy, Chairman, Pharmexcil
11:40 - 11:50 AM - Key Note Address
Mr Shyamal Misra, Joint Secretary, IAS, Department of Commerce, Govt of India
12:05 - 12:20 PM - Panel Discussion
"Accessibility of Affordable Medicines: Cost of Regulation vis-a-vis-Cost of Medicines"
12:20 - 01:20 PM - Key Note Address
Mr Shyamal Misra, Joint Secretary, IAS, Department of Commerce, Govt of India
12:05 - 12:20 PM - Session Moderator:
Dr Dinesh Dua, Vice Chairman, Pharmexcil - Panel Members:
a.Dr G N Singh, DCGI
b.Dr Yusuf K Hameid, Non-Executive Chairman, CIPLA
c.Dr Ajit Singh, Chairman, ACG WorldWide
d.Mr Rakesh Bamzai, SVP & President Commercial, India and Emerging Markets, Mylan Inc,
e.Senior Representatives Associations and Global NGOs - Q&A Session
01:00 - 01:15 PM - Vote of Thanks - PHARMEXCIL
01:15 - 01:20PM - Click here Full Details
Trade/commodity Facts
- WORLD RENOWNED QUALITY
Indian has about 1400 WHO GMP approved manufacturing units. - A HELPING HAND
Approximately 70 per cent of the patients in developing countries receive Indian medicines through NGOs like The Clinton Foundation, Bill & Melinda Gates Foundation - HOME TO EXCELLENCE
7 out of top 20 generic companies are from India. - IN THE PREMIER LEAGUE
30 per cent of total Abbreviated New Drug Applications (ANDAs) are from India - TRUSTED QUALITY
Around 55 per cent India’s exports are to highly regulated markets
Highlights
- India’s generics cover all the Therapeutic segments with adequate & convenient dosage forms in each of them
Potential Speakers
- Kate Kuhrt
Head of GTM – Life Sciences
Company: Clarivate Analytics
(Synergy of Global Opportunities and also in Panel Discussion) - Ajaz S. Hussain
President, NIPTE | Founder, Insight, Advice & Solutions LLC.
Insight, Advice & Solutions LLC.
(Panel Discussion) - Aurelio Arias
Senior Consultant, European Thought Leadership QuintilesIMS
(Panel Discussion) - Peter Hofland
Executive Editor
InPress Media Group LLC
(Panel Discussion) - Johnathon Marshall
Pharma & Life Sciences Advisory Partner
PricewaterhouseCoopers
(Topic: Synergy of Global Opportunities and also in Panel Discussion) - Jim Miller
President & Owner
PharmSource
(Topic: Synergy of Global Opportunities and also in Panel Discussion) - Sergio Napolitano
Director Legal, Trade & Public Affairs
Medicines for Europe
(Topic: Synergy of Global Opportunities and also in Panel Discussion) - Marc-Alexander Mahl
Executive Vice President Business Unit Generic Drugs
Fresenius Kabi
(Panel Discussion)